Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
3,424
Showing 50 of 3,424
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 101 | GTII | Global Tech Industries Group, Inc. | 78 | 4 | 90% | +37.0% | +37.1% | +82.5% | -32.9% |
| 102 | SENS | Senseonics Holdings, Inc. | 18/21 | 11 | 89% | +36.8% | +38.6% | +89.6% | -15.0% |
| 103 | VERO | Venus Concept Inc. | 80/88 | 16 | 96% | +36.7% | +42.5% | +49.1% | -43.7% |
| 104 | RLMD | Relmada Therapeutics, Inc. | 42 | 6 | 57% | +36.5% | +30.5% | +550.5% | -84.4% |
| 105 | FFWM | First Foundation Inc. | 21 | 10 | 76% | +36.3% | +56.8% | +78.6% | -46.6% |
| 106 | OPRX | Optimizerx Corp | 12 | 6 | 100% | +36.1% | +30.6% | +93.7% | +15.6% |
| 107 | BBWI | Bath & Body Works, Inc. | 13 | 10 | 92% | +35.7% | +44.7% | +62.6% | -11.0% |
| 108 | ALTO | Alto Ingredients, Inc. | 14/16 | 6 | 100% | +35.7% | +32.2% | +78.7% | +9.9% |
| 109 | KZR | Kezar Life Sciences, Inc. | 24 | 5 | 79% | +35.5% | +62.6% | +65.8% | -69.2% |
| 110 | BKKT | Bakkt Holdings, Inc. | 81/90 | 15 | 83% | +35.2% | +37.9% | +113.6% | -111.7% |
| 111 | MYSZ | My Size, Inc. | 20 | 5 | 70% | +35.1% | +67.6% | +70.7% | -43.5% |
| 112 | TOI | Oncology Institute, Inc. | 74/87 | 19 | 76% | +35.1% | +27.7% | +391.3% | -45.3% |
| 113 | CPIX | Cumberland Pharmaceuticals Inc | 934 | 6 | 39% | +34.9% | -8.3% | +473.7% | -57.2% |
| 114 | CORZ | Core Scientific, Inc./Tx | 39/61 | 9 | 64% | +34.9% | +41.9% | +188.0% | -160.5% |
| 115 | NMRA | Neumora Therapeutics, Inc. | 186 | 26 | 90% | +34.8% | +35.4% | +87.0% | -24.2% |
| 116 | NG | Novagold Resources Inc | 27 | 17 | 89% | +34.8% | +44.1% | +107.3% | -36.1% |
| 117 | RELI | Reliance Global Group, Inc. | 20/22 | 7 | 75% | +34.6% | +58.2% | +76.6% | -52.3% |
| 118 | BMRC | Bank of Marin Bancorp | 19/20 | 12 | 100% | +34.3% | +42.8% | +50.7% | +6.6% |
| 119 | PSIX | Power Solutions International, Inc. | 397 | 9 | 91% | +34.3% | +32.0% | +523.3% | -198.3% |
| 120 | UONE/UONEK | Urban One, Inc. | 12/19 | 7 | 92% | +33.7% | +39.2% | +48.7% | -3.7% |
| 121 | CVRX | Cvrx, Inc. | 54 | 10 | 87% | +33.6% | +31.8% | +81.6% | -37.0% |
| 122 | MOBX | Chavant Capital Acquisition Corp. | 15/17 | 7 | 87% | +33.5% | +36.7% | +61.3% | -23.9% |
| 123 | BENF | Beneficient | 74 | 4 | 85% | +33.5% | +47.3% | +67.3% | -82.8% |
| 124 | SANA | Sana Biotechnology, Inc. | 95 | 24 | 98% | +33.4% | +54.1% | +68.8% | -125.7% |
| 125 | YELLQ | Yellow Corp | 52 | 17 | 62% | +33.4% | +19.8% | +109.9% | -71.8% |
| 126 | ZI | Zoominfo Technologies Inc. | 779/792 | 24 | 95% | +33.2% | +38.2% | +46.6% | -26.2% |
| 127 | STTK | Shattuck Labs, Inc. | 26/28 | 13 | 69% | +32.9% | +17.4% | +107.2% | -49.3% |
| 128 | SNWV | Sanuwave Health, Inc. | 65/76 | 8 | 95% | +32.9% | +24.8% | +102.2% | -39.6% |
| 129 | UAVS | Ageagle Aerial Systems Inc. | 25 | 9 | 96% | +32.9% | +31.9% | +124.7% | -27.0% |
| 130 | RNXT | Renovorx, Inc. | 32/36 | 8 | 84% | +32.8% | +19.3% | +88.6% | -17.2% |
| 131 | DKDCA | Data Knights Acquisition Corp. | 77/81 | 6 | 70% | +32.6% | +29.0% | +181.2% | -66.2% |
| 132 | LOCL | Local Bounti Corporation/De | 79/81 | 13 | 82% | +32.6% | +36.0% | +70.4% | -42.1% |
| 133 | CRDF | Cardiff Oncology, Inc. | 10 | 3 | 40% | +32.6% | -3.2% | +280.1% | -24.3% |
| 134 | ADV | Advantage Solutions Inc. | 83/90 | 11 | 72% | +32.6% | +33.8% | +139.1% | -23.5% |
| 135 | HOWL | Werewolf Therapeutics, Inc. | 424/473 | 19 | 92% | +31.8% | +34.1% | +61.6% | -67.0% |
| 136 | ENGN | Engene Holdings Inc. | 32 | 4 | 94% | +31.8% | +6.5% | +145.2% | -20.2% |
| 137 | MAZE | Maze Therapeutics, Inc. | 31/55 | 6 | 97% | +31.7% | +29.8% | +42.9% | -70.8% |
| 138 | INTG | Intergroup Corp | 20 | 3 | 100% | +31.6% | +39.9% | +41.8% | +13.2% |
| 139 | ETST | Earth Science Tech, Inc. | 180 | 6 | 51% | +31.5% | +2.2% | +293.9% | -53.0% |
| 140 | HNRG | Hallador Energy Co | 47 | 3 | 74% | +31.5% | +13.7% | +133.1% | -21.1% |
| 141 | WWR | Westwater Resources, Inc. | 24/27 | 7 | 83% | +31.4% | +37.9% | +53.0% | -7.0% |
| 142 | SYRA | Syra Health Corp | 31 | 4 | 81% | +31.4% | +42.8% | +75.0% | -68.3% |
| 143 | EAF | Graftech International Ltd | 1,285 | 28 | 99% | +31.2% | +30.8% | +52.8% | -69.7% |
| 144 | NAUT | Nautilus Biotechnology, Inc. | 20 | 6 | 55% | +30.9% | +3.1% | +219.0% | -29.2% |
| 145 | WVE | Wave Life Sciences Ltd. | 97/113 | 17 | 89% | +30.7% | +28.2% | +99.0% | -142.9% |
| 146 | ENVX | Enovix Corp | 31 | 11 | 74% | +30.6% | +26.9% | +174.4% | -173.3% |
| 147 | VHC | Virnetx Holding Corp | 15 | 4 | 67% | +30.4% | +45.8% | +72.2% | -26.8% |
| 148 | MNTS | Momentus Inc. | 491/496 | 9 | 85% | +30.4% | +35.7% | +88.8% | -5.6% |
| 149 | GALT | Galectin Therapeutics Inc | 127/128 | 11 | 81% | +30.3% | +44.0% | +114.8% | -85.4% |
| 150 | UHG | United Homes Group, Inc. | 38/42 | 17 | 61% | +30.2% | +2.2% | +115.5% | -23.5% |